Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
232 studies found for:    Open Studies | "Colitis, Ulcerative"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Colitis, Ulcerative"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting The Utility of Second Generation Colon Capsule Endoscopy in Ulcerative Colitis
Condition: Colitis, Ulcerative
Interventions: Device: C2 videos;   Procedure: colonoscopy
2 Recruiting GSK2982772 Study in Ulcerative Colitis Patients
Condition: Colitis, Ulcerative
Interventions: Drug: GSK2982772;   Drug: Placebo
3 Recruiting Efficacy, Pharmacokinetics, Tolerability, Safety of SB012 Intrarectally Applied in Active Ulcerative Colitis Patients
Condition: Colitis, Ulcerative
Interventions: Drug: SB012;   Drug: Placebo
4 Not yet recruiting Mercaptopurine Therapy in Ulcerative Colitis
Condition: Colitis, Ulcerative
Interventions: Drug: Mercaptopurine (Purinethol);   Drug: Placebo;   Drug: Mesalamine;   Drug: Prednisone
5 Recruiting Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Condition: Colitis, Ulcerative
Intervention: Drug: Vedolizumab IV
6 Recruiting Confocal Laser Endomicroscopy for Assessment of Mucosal Healing in Ulcerative Colitis
Condition: Colitis, Ulcerative
Intervention:
7 Recruiting An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis
Condition: Colitis, Ulcerative
Interventions: Drug: LYC-30937-EC;   Drug: Placebo
8 Recruiting Open-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative Colitis
Condition: Colitis, Ulcerative
Intervention: Drug: LYC-30937-EC
9 Recruiting Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.
Condition: Colitis, Ulcerative
Intervention: Drug: PF-06480605
10 Recruiting An Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative Colitis
Condition: Colitis, Ulcerative
Intervention: Drug: Vedolizumab 300 mg
11 Recruiting Correlation of Soluble ST2 With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022).
Condition: Colitis, Ulcerative
Intervention: Biological: Golimumab
12 Recruiting An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis
Condition: Colitis, Ulcerative
Interventions: Drug: Vedolizumab;   Drug: Adalimumab placebo;   Drug: Adalimumab;   Drug: Vedolizumab placebo
13 Recruiting Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis
Condition: Colitis, Ulcerative
Interventions: Drug: Vedolizumab IV 300 mg;   Drug: Placebo IV;   Drug: Vedolizumab SC 108 mg;   Drug: Placebo SC
14 Recruiting A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors
Condition: Colitis, Ulcerative
Interventions: Drug: Etrolizumab;   Drug: Placebo
15 Not yet recruiting This Study Tests How BI 655130 Works in Patients With Active Ulcerative Colitis. The Study Also Tests How Well BI 655130 is Tolerated and Whether it Helps the Patients
Condition: Colitis, Ulcerative
Intervention: Drug: BI 655130
16 Not yet recruiting A Study in Patients With Mild or Moderate Ulcerative Colitis Who Take a TNF Inhibitor. The Study Investigates Whether Bowel Inflammation Improves When Patients Take BI 655130 in Addition to Their Current Therapy
Condition: Colitis, Ulcerative
Interventions: Drug: BI 655130;   Drug: Placebo
17 Not yet recruiting Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not?
Condition: Colitis,Ulcerative
Interventions: Other: Discontinuation of anti-TNF treatment;   Other: Continuation of anti-TNF treatment
18 Recruiting Faecal Bacteriotherapy for Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Other: Faecal bacterial transplantation;   Drug: Mesalazine 4G Enema
19 Recruiting Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects With Moderate to Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: Adalimumab;   Other: Placebo
20 Recruiting Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Infliximab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.